Space Florida And SPACEHAB, Inc. To Send Validation Of Salmonella Vaccine Target To The Space Station On Upcoming Mission Of Space Shuttle Discovery
June 2nd, 2008 by 
admin A partnership between Space Florida and SPACEHAB’s newborn biotech supplementary BioSpace Technologies Inc. paves the artefact to amend binary immunogen targets on the International Space Station (ISS). “This newborn expanse geezerhood microgravity impact is already disclosing newborn opportunities in the utilization of life-saving biomedicines within Florida’s newborn biotech expanse corridor,” said saint Pickens, III, chair and honcho chief officer, SPACEHAB, Inc.
Tags: Medicine, Subsidiary, Technologies Inc
Posted in Immunology | 